EP2 and EP4 prostanoid receptor signaling

被引:363
|
作者
Regan, JW [1 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
关键词
G-protein coupled receptors; prostaglandins; PGE2; cAMP; cancer;
D O I
10.1016/j.lfs.2003.09.031
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The EP2 and EP4 prostanoid receptors are two of the four subtypes of receptors for prostaglandin E-2 (PGE(2)). They are in the family of G-protein coupled receptors and both receptors were initially characterized as coupling to Gs and increasing intracellular cAMP formation. Recently, however, we have shown that both receptors can stimulate T-cell factor (Tcf) mediated transcriptional activity. The EP2 receptor does this primarily through cAMP-dependent protein kinase (PKA), whereas the EP4 utilizes phosphatidylinositol 3-kinase (PI3K) as well as PKA. In addition, we have shown that the EP4 receptor, but not the EP2, can activate the extracellular signal-regulated kinases (ERKs) I and 2 by way of PI3K leading to the induction of early growth response factor-1 (EGR-1), a transcription factor traditionally associated with wound healing. This induction of EGR-1 expression has significant implications concerning the potential role of PGE(2) in cancer and inflammatory disorders. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [41] Localization of prostaglandin E2 EP2 and EP4 receptors in the rat kidney
    Jensen, BL
    Stubbe, J
    Hansen, PB
    Andreasen, D
    Skott, O
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (06) : F1001 - F1009
  • [42] Characterization of prostaglandin E2 receptors (EP2, EP4) in the horse oviduct
    Ball, B. A.
    Scoggin, K. E.
    Troedsson, M. H. T.
    Squires, E. L.
    ANIMAL REPRODUCTION SCIENCE, 2013, 142 (1-2) : 35 - 41
  • [43] PGE2 decreases reactivity of human platelets by activating EP2 and EP4
    Smith, James P.
    Haddad, Elias V.
    Downey, Jason D.
    Breyer, Richard M.
    Boutaud, Olivier
    THROMBOSIS RESEARCH, 2010, 126 (01) : E23 - E29
  • [44] E-type prostanoid receptor 4 (EP4) in disease and therapy
    Konya, Viktoria
    Marsche, Gunther
    Schuligoi, Rufina
    Heinemann, Akos
    PHARMACOLOGY & THERAPEUTICS, 2013, 138 (03) : 485 - 502
  • [45] Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules
    Vleeshouwers, Ward
    van den Dries, Koen
    de Keijzer, Sandra
    Joosten, Ben
    Lidke, Diane S.
    Cambi, Alessandra
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [46] Cooperation of two subtypes of PGE2 receptor, gi coupled EP3 and gs coupled EP2 or EP4 subtype
    Hatae, N
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2003, 123 (10): : 837 - 843
  • [47] PGE2 May Decrease Airway Inflammation and Muscular Hyperplasia in Eosinophilic Bronchitis Patients through Prostanoid Receptors EP2 and EP4
    Sastre, B.
    Fernandez-Nieto, M.
    Lopez, E.
    Gamez, C.
    Aguado, E.
    Quirce, S.
    Sastre, J.
    Del Pozo, V.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB44 - AB44
  • [48] Prostanoid receptors in hyperfiltration-mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors
    Srivastava, Tarak
    Garola, Robert E.
    Zhou, Jianping
    Boinpelly, Varun C.
    Priya, Lakshmi
    Ali, Mohammed Farhan
    Rezaiekhaligh, Mohammad H.
    Heruth, Daniel P.
    Novak, Jan
    Alon, Uri S.
    Joshi, Trupti
    Jiang, Yuexu
    McCarthy, Ellen T.
    Savin, Virginia J.
    Johnson, Mark L.
    Sharma, Ram
    Sharma, Mukut
    FASEB JOURNAL, 2022, 36 (10):
  • [49] IDENTIFICATION OF PROSTAGLANDIN-E RECEPTOR EP2 CLONED FROM MASTOCYTOMA-CELLS AS EP4 SUBTYPE
    NISHIGAKI, N
    NEGISHI, M
    HONDA, A
    SUGIMOTO, Y
    NAMBA, T
    NARUMIYA, S
    ICHIKAWA, A
    FEBS LETTERS, 1995, 364 (03) : 339 - 341
  • [50] Expression of the prostaglandin E2 receptors EP1, EP2, EP3 and EP4 in human kidney
    Morath, R
    Klein, T
    Seyberth, HW
    Nüsing, RM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R725 - R725